Read More 1 minute read Analyst Ratings News Price Target Barclays Maintains Overweight on Federal Realty Investment, Lowers Price Target to $122 By Benzinga Newsdesk July 15, 7:11 AM Barclays analyst Anthony Powell maintains Federal Realty Investment (NYSE:FRT) with a Overweight and lowers the price target from $142 to $122. FRT
Read More 1 minute read Analyst Ratings Downgrades News William Blair Downgrades 10x Genomics to Market Perform By Benzinga Newsdesk July 15, 7:09 AM William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform. TXG
Read More 1 minute read Analyst Ratings News Barclays Maintains Overweight on Amazon.com. Price adjusts to $195 By Benzinga Newsdesk July 15, 7:06 AM Barclays analyst Ross Sandler maintains Amazon.com (NASDAQ:AMZN) with a Overweight. Price adjusts to $195 AMZN
Read More 1 minute read Analyst Ratings News Price Target UBS Maintains Neutral on Netflix, Lowers Price Target to $198 By Benzinga Newsdesk July 15, 7:05 AM UBS analyst John Hodulik maintains Netflix (NASDAQ:NFLX) with a Neutral and lowers the price target from $355 to $198. NFLX
Read More 1 minute read Analyst Ratings News Price Target Citigroup Maintains Neutral on Conagra Brands, Lowers Price Target to $35 By Benzinga Newsdesk July 15, 7:03 AM Citigroup analyst Wendy Nicholson maintains Conagra Brands (NYSE:CAG) with a Neutral and lowers the price target from $37 to $35. CAG
Read More 1 minute read Analyst Ratings News Price Target Barclays Maintains Overweight on Hess, Lowers Price Target to $149 By Benzinga Newsdesk July 15, 6:59 AM Barclays analyst Jeanine Wai maintains Hess (NYSE:HES) with a Overweight and lowers the price target from $153 to $149. HES
Read More 1 minute read Analyst Ratings News Price Target SVB Leerink Maintains Outperform on Tenet Healthcare, Lowers Price Target to $68 By Benzinga Newsdesk July 15, 6:57 AM SVB Leerink analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and lowers the price target from $110 to $68. THC
Read More 1 minute read Analyst Ratings Cannabis Markets News Price Target Roth Capital Maintains Neutral on Tilray, Lowers Price Target to $4 By Benzinga Newsdesk July 15, 6:52 AM Roth Capital analyst Scott Fortune maintains Tilray (NASDAQ:TLRY) with a Neutral and lowers the price target from $8 to $4. TLRY
Read More 1 minute read Analyst Ratings News Price Target Credit Suisse Maintains Outperform on JPMorgan Chase, Lowers Price Target to $145 By Benzinga Newsdesk July 15, 6:40 AM Credit Suisse analyst Susan Roth Katzke maintains JPMorgan Chase (NYSE:JPM) with a Outperform and lowers the price target from $160 to $145. JPM
Read More 1 minute read Analyst Ratings News Price Target Barclays Maintains Overweight on JPMorgan Chase, Lowers Price Target to $162 By Benzinga Newsdesk July 15, 6:38 AM Barclays analyst Jason Goldberg maintains JPMorgan Chase (NYSE:JPM) with a Overweight and lowers the price target from $200 to $162. JPM